India
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
39.38%
|
March 31, 2024 | USD 25.80 | 12.75% |
|
India |
|
2 |
36.03%
|
March 31, 2024 | USD 13.60 | -0.27% |
|
India |
|
3 |
11.98%
|
March 31, 2024 | USD 21.80 | 0.20% |
|
India |
|
4 |
5.50%
|
March 31, 2024 | USD 17.12 | 0.17% |
|
India |
|
5 |
0.16%
|
March 31, 2024 | USD 4.90 | 9.41% |
|
India |
|
6 |
-1.08%
|
March 31, 2024 | USD 18.85 | -0.37% |
|
India |
|
7 |
-4.12%
|
March 31, 2024 | USD 11.90 | 11.12% |
|
India |
The Vaccines company in India with the highest Operating Income Margin is GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO.NS) at 39.38%.
The Vaccines company in India with the lowest Operating Income Margin is Vimta Labs Limited (NSE: VIMTALABS.NS) at -4.12%.
The top 10 Vaccines companies in India by Operating Income Margin are GlaxoSmithKline Pharmaceuticals Limited, Aurobindo Pharma Limited, Hester Biosciences Limited, Glenmark Pharmaceuticals Limited, Panacea Biotec Limited, Wockhardt Limited and Vimta Labs Limited.
The bottom 10 Vaccines companies in India by Operating Income Margin are Vimta Labs Limited, Wockhardt Limited, Panacea Biotec Limited, Glenmark Pharmaceuticals Limited, Hester Biosciences Limited, Aurobindo Pharma Limited and GlaxoSmithKline Pharmaceuticals Limited.